Literature DB >> 2222551

In vitro studies on interactions of iron salts and complexes with food-stuffs and medicaments.

P Geisser1.   

Abstract

It has been shown in the present study that food components such as phytic acid, oxalic acid, tannin, sodium alginate, choline and choline salts, vitamins A, D3 and E, soy oil and soy flour, do not undergo any interactions with iron(III)-hydroxide polymaltose complex (Ferrum Hausmann). Phytic acid, oxalic acid, tannin and sodium alginate, however, react with iron(II) or iron(III)-salts at pH values of 3.0, 5.5 and 8.0, giving rise to iron complexes. Trimethylamine-N-oxide, which is present in fish meal, reacts with iron(II)-sulphate to produce iron(III) reaction products; it does not react with iron(III)-hydroxide polymaltose complex. Special soybean flours show no irreversible adsorption or precipitation with iron(III)-hydroxyide polymaltose complex over the pH range 3.0-8.0, in contrast to iron(II)-sulphate. Antacids containing aluminium hydroxide, talc, ion exchange resins or other unabsorbable, insoluble components absorb iron(III)-hydroxide polymaltose complex in the pH range 3.0-8.0 in a reversible manner, while the strong adsorption or precipitation observed with iron(II)-sulphate at pH 8.0 is irreversible. No interaction was observed between the steroid hormones studied and iron(II)-sulphate or iron(III)-hydroxide polymaltose complex. On the basis of the measured compatibilities, iron(III)-hydroxide polymaltose complex can be administered orally simultaneously with many other drugs, without prejudicing the absorption of iron or of the other drug as is often seen with iron(II) and iron(III) salts.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222551

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

Review 1.  Diagnosis and management of iron deficiency anemia in patients with IBD.

Authors:  Jürgen Stein; Franz Hartmann; Axel U Dignass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

2.  Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women.

Authors:  Lekha Saha; Promila Pandhi; Sarala Gopalan; Samir Malhotra; Pradip Kumar Saha
Journal:  MedGenMed       Date:  2007-01-02

3.  Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.

Authors:  Gary R Lichtenstein; Jane E Onken
Journal:  Dig Dis Sci       Date:  2018-07-28       Impact factor: 3.199

Review 4.  Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy.

Authors:  Alhossain A Khalafallah; Amanda E Dennis
Journal:  J Pregnancy       Date:  2012-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.